FindTrial
Sign In

Topical coating of measles-mumps-rubella vaccine for the treatment of respiratory papilloma

Topical coating of measles-mumps-rubella vaccine for the treatment of respiratory papilloma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001370
Enrollment
Unknown
Registered
2011-05-27
Start date
2009-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent respiratory papilloma (RRP)

Interventions

control group:Debulk laryngeal neoplasm with microdebrider
intervention group:Debulk laryngeal neoplasm with microdebrider, then topical coat MMR vaccine on the lesion and keep it for 10 minutes.

Sponsors

Eye and ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 18 Years

Inclusion criteria

Inclusion criteria: younger than 18-year-old when first diagnosed with RRP

Exclusion criteria

Exclusion criteria: older than 18-year-old when first diagnosed with RRP

Design outcomes

Primary

MeasureTime frame
the number of days between the first and second surgery;—

Secondary

MeasureTime frame
the score of the staging assessment sheet;—

Countries

China

Contacts

Public ContactLei JIN
jinlei0511@hotmail.com+86 21 64377124-383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026